Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

Tarlatamab improved PFS and OS over chemotherapy as second-line treatment in patients with SCLC in the phase 3 DeLLphi-304 trial.

CAR T-cell therapy has the potential to revolutionise how we treat certain types of cancer by genetically engineering someone’s own immune cells to attack the disease – but it is also ...

Key Takeaways Metastatic breast cancer subtypes and biomarkers are crucial for guiding treatment decisions and managing disease progression. ER-positive, HER2-negative breast cancer treatment often ...

An innovative one-time treatment that harnesses a patient’s own immune system to fight advanced melanoma could help people with the deadly form of skin cancer live longer, researchers have ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing brain cancer. Tumors became smaller after the experimental CAR T cell ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal cancer, one of the deadliest types of cancers that has been rising in ...

The dietary bug in a cancer therapy Date: May 21, 2025 Source: Ludwig Institute for Cancer Research Summary: A study has uncovered a surprising link between diet, intestinal microbes and the ...

Prostate cancer is one of the most common cancers in men. Although watchful waiting is appropriate for low-risk cases, many are diagnosed at an advanced stage because of racial health disparities.

Proton therapy may reduce urinary, bowel and sexual side effects in prostate cancer by minimizing radiation exposure to healthy tissue, per Dr. Curtiland Deville Jr. Newer radiation technologies, such ...

Prostate cancer is among the most common forms of cancer in older men. The American Cancer Society estimates there will be about 313,780 new diagnoses of the condition and 35,770 deaths attributed ...